Skip to content
EU Startups News
  • Funding
  • Launch
  • Partnership
  • Acquisition
  • Policy
  • Exit & IPO

Reveal Genomics

Hologic to Acquire Spanish Precision Oncology Startup Reveal Genomics

October 26, 2026 by Marco Bianchi

Hologic announced a definitive agreement to acquire Spanish startup Reveal Genomics, marking a major milestone for the company and expanding Hologic’s portfolio in precision oncology. The deal will integrate Reveal’s breast‑cancer genomic testing platform into Hologic’s women’s‑health technology suite.

Categories Acquisition Tags Healthtech, Reveal Genomics, Spain Leave a comment
Browse by Country

Latest

Sicilian Deeptech Startup Archimede Secures €1.5 Million for Industrial IoT Mesh Connectivity PlatformOct 26, 2026
Spire Capital Partners backs Krakow-based GoPOS to consolidate Poland's fragmented HoReCa tech marketOct 26, 2026
Alastria Announces 12 Finalists for Fourth Edition of Blockchain AwardsOct 26, 2026
Hologic to Acquire Spanish Precision Oncology Startup Reveal GenomicsOct 26, 2026
Swedish Fashion E-Commerce Platform Boozt Cuts Senior Positions in Restructuring DriveOct 26, 2026

EU Markets

European Startups, Brace Yourselves: Rate Pressures, AI Disruption, and a €550M Legal Tech Unicorn Define This Week's Financial LandscapeOct 23, 2026
French Debt Fears, AI Tailwinds, and a New Unicorn: What Europe's Financial Markets Mean for Your Startup This WeekOct 16, 2026
European Markets Flash Warning Signs and Green Lights for Startups This WeekOct 9, 2026
European Fintech Expands, Crypto Matures, and Capital Shifts: What This Week's Financial News Means for StartupsOct 2, 2026

EU Startups News
• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.